J. William Langston

Parkinsonism Induced By 1-Methyl-4-Phenyl-1, 2, 3, 6-Tetrahydropyridine (MPTP): Implications for Treatment and the Pathogenesis of Parkinson’s Disease

P. Ballard, J. William Langston, 1984, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

Whole genome survey of coding SNPs reveals a reproducible pathway determinant of Parkinson disease

Mostafa Ronaghi, Balaji S. Srinivasan, Ronald W Davis, 2008, Human mutation.

Dietary fat intake, pesticide use, and Parkinson's disease.

C. Tanner, Honglei Chen, J. Hoppin, 2014, Parkinsonism & related disorders.

Selegiline and Parkinson’s Disease

I. Shoulson, L. Golbe, J. William Langston, 1990, Drugs.

Heart rate variability in leucine‐rich repeat kinase 2‐associated Parkinson's disease

C. Tanner, E. Rogaeva, Drew S. Kern, 2017, Movement disorders : official journal of the Movement Disorder Society.

Selective accumulation of MPP+ in the substantia nigra: a key to neurotoxicity?

J. Langston, I. Irwin, J. William Langston, 1985, Life sciences.